Skip to content

DR. Wouter Cortens, Huisarts

Active
Private limited companyfounded 2023active for 3 yearsWalbosstraat 55, 9070 Destelbergen, BelgiumKBO/BCE: BE 0803.728.835
Summary

DR. Wouter Cortens, Huisarts has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €2,048 and a net result of €73,573. Equity is shrinking by about 47% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 5% of 323 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
≈ €220,000turnover 2026, estimated
Staff
≈ 0 FTE, estimated
Equity
€2,048
Profit
€73,573
Turnover estimated from the gross margin
Financial health
91 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
  • CORTENS WouterDirector
2026 accounts 11 days early
Why 91raises riskEquity €2,048 (1.0% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.98, cash €173,818Size: total assets €203,156Show the evidence

Checked score

Score 2026
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 27% of its sector peers (NACE 86, micro)
Financial strength · tick = 2025
Average
Solvency 26-74
equity 1.0% of total assets
Liquidity 50-45
short-term debt 99.0% · cash 85.6%
Profitability 100=
return on assets 36.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 5% on solvency, 20% on liquidity, 80% on profitability and 3% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.98, cash €173,818
NBB · annual accounts
lowers risk · Size: total assets €203,156
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €2,048 (1.0% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 323 sector peers (2026).
NBB · sector comparison
Position among 323 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 20-10-2026, 11 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2026
11 days early
2025
9 days early
2024
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 7 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 22 October (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Highest result from 2024 to 2026net €73,573 ▲3.3%
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Caution: Equity fell in 2026from €105,876 to €2,048 ▼ 98.1% View
  • Caution: Among the weakest 5% on solvencysector median 74.4% · 323 companies 1.0% View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2026
Total assets
€203,156
Profit
€73,573
Solvency
1.0%
Total assets▲ 55.9%
Net result
20242026
Go to Financials

Timeline

Events
7
Since
2023
Next accounts
by 31-10-2027
  1. 31-03-2025Liquidity more than doubled
  2. 31-03-2025Equity above €100,000
  3. 30-10-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
07-07-2023
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
41
Who signs
A managing director alone, or each director alone
Annual meeting
Last Friday of September at 20:00
Go to Articles of association

Key facts about DR. Wouter Cortens, Huisarts

What is the company number of DR. Wouter Cortens, Huisarts?
0803.728.835. In Belgium the VAT number is the company number with BE in front: BE 0803.728.835.
Where is DR. Wouter Cortens, Huisarts based?
The registered office is at Walbosstraat 55, 9070 Destelbergen.Company details
What does DR. Wouter Cortens, Huisarts do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. Wouter Cortens, Huisarts?
Private limited company (BV).
When was DR. Wouter Cortens, Huisarts founded?
On 07-07-2023.
Is DR. Wouter Cortens, Huisarts still active?
Yes, DR. Wouter Cortens, Huisarts is an active enterprise in the KBO register.
What is the turnover of DR. Wouter Cortens, Huisarts?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. Wouter Cortens, Huisarts profitable?
In financial year 2026, DR. Wouter Cortens, Huisarts made a profit of €73,573.
Where can I find the annual accounts of DR. Wouter Cortens, Huisarts?
DR. Wouter Cortens, Huisarts filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of DR. Wouter Cortens, Huisarts due?
By 31-10-2027, for financial year 2027.Timeline

Companies related to DR. Wouter Cortens, Huisarts

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.